Global Nuclear Medicine & Radiopharmaceuticals Market Growth 2022-2028
As the global economy mends, the 2021 growth of Nuclear Medicine & Radiopharmaceuticals will have significant change from previous year. According to our latest study, the global Nuclear Medicine & Radiopharmaceuticals market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Nuclear Medicine & Radiopharmaceuticals market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Nuclear Medicine & Radiopharmaceuticals market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nuclear Medicine & Radiopharmaceuticals market, reaching US$ million by the year 2028. As for the Europe Nuclear Medicine & Radiopharmaceuticals landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nuclear Medicine & Radiopharmaceuticals players cover China Isotope & Radiation, Dongcheng, Jaco, and Ciaeriar, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine & Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diagnostic
Therapeutic
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oncology
Thyroid
Cardiology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nuclear Medicine & Radiopharmaceuticals by Country/Region, 2017, 2022 & 2028
2.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic
2.2.2 Therapeutic
2.3 Nuclear Medicine & Radiopharmaceuticals Sales by Type
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2017-2022)
2.4 Nuclear Medicine & Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.4.4 Others
2.5 Nuclear Medicine & Radiopharmaceuticals Sales by Application
2.5.1 Global Nuclear Medicine & Radiopharmaceuticals Sale Market Share by Application (2017-2022)
2.5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2017-2022)
3 Global Nuclear Medicine & Radiopharmaceuticals by Company
3.1 Global Nuclear Medicine & Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Company (2020-2022)
3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2020-2022)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Company (2020-2022)
3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2020-2022)
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Location Distribution
3.4.2 Players Nuclear Medicine & Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nuclear Medicine & Radiopharmaceuticals by Geographic Region
4.1 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Geographic Region (2017-2022)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Geographic Region
4.2 World Historic Nuclear Medicine & Radiopharmaceuticals Market Size by Country/Region (2017-2022)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue by Country/Region
4.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.4 APAC Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.5 Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth
5 Americas
5.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country
5.1.1 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022)
5.1.2 Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022)
5.2 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type
5.3 Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region
6.1.1 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2017-2022)
6.1.2 APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2017-2022)
6.2 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type
6.3 APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nuclear Medicine & Radiopharmaceuticals by Country
7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022)
7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022)
7.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type
7.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals by Country
8.1.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022)
8.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type
8.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
10.4 Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Medicine & Radiopharmaceuticals Distributors
11.3 Nuclear Medicine & Radiopharmaceuticals Customer
12 World Forecast Review for Nuclear Medicine & Radiopharmaceuticals by Geographic Region
12.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Region (2023-2028)
12.1.2 Global Nuclear Medicine & Radiopharmaceuticals Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Type
12.7 Global Nuclear Medicine & Radiopharmaceuticals Forecast by Application
13 Key Players Analysis
13.1 China Isotope & Radiation
13.1.1 China Isotope & Radiation Company Information
13.1.2 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offered
13.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 China Isotope & Radiation Main Business Overview
13.1.5 China Isotope & Radiation Latest Developments
13.2 Dongcheng
13.2.1 Dongcheng Company Information
13.2.2 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offered
13.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Dongcheng Main Business Overview
13.2.5 Dongcheng Latest Developments
13.3 Jaco
13.3.1 Jaco Company Information
13.3.2 Jaco Nuclear Medicine & Radiopharmaceuticals Product Offered
13.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Jaco Main Business Overview
13.3.5 Jaco Latest Developments
13.4 Ciaeriar
13.4.1 Ciaeriar Company Information
13.4.2 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offered
13.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ciaeriar Main Business Overview
13.4.5 Ciaeriar Latest Developments
13.5 Advanced Molecular-imaging Solution
13.5.1 Advanced Molecular-imaging Solution Company Information
13.5.2 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offered
13.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Advanced Molecular-imaging Solution Main Business Overview
13.5.5 Advanced Molecular-imaging Solution Latest Developments
13.6 Shanghai Atom Kexing
13.6.1 Shanghai Atom Kexing Company Information
13.6.2 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offered
13.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Shanghai Atom Kexing Main Business Overview
13.6.5 Shanghai Atom Kexing Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nuclear Medicine & Radiopharmaceuticals Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diagnostic
Table 4. Major Players of Therapeutic
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2017-2022) & ($ million)
Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Table 9. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2017-2022)
Table 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2017-2022)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Nuclear Medicine & Radiopharmaceuticals Sales by Company (2020-2022) & (K Units)
Table 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Company (2020-2022)
Table 17. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company (2020-2022)
Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 21. Players Nuclear Medicine & Radiopharmaceuticals Products Offered
Table 22. Nuclear Medicine & Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nuclear Medicine & Radiopharmaceuticals Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Geographic Region (2017-2022)
Table 27. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Nuclear Medicine & Radiopharmaceuticals Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country/Region (2017-2022)
Table 31. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 34. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 35. Americas Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 38. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 39. Americas Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 40. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 41. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 42. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Table 43. APAC Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
Table 45. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 46. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 47. APAC Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 48. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 49. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 50. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 51. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 53. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 54. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 55. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 56. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Nuclear Medicine & Radiopharmaceuticals
Table 66. Key Market Challenges & Risks of Nuclear Medicine & Radiopharmaceuticals
Table 67. Key Industry Trends of Nuclear Medicine & Radiopharmaceuticals
Table 68. Nuclear Medicine & Radiopharmaceuticals Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 71. Nuclear Medicine & Radiopharmaceuticals Customer List
Table 72. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Forecast by Region
Table 74. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Application (2023-2028)
Table 92. China Isotope & Radiation Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 93. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 94. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. China Isotope & Radiation Main Business
Table 96. China Isotope & Radiation Latest Developments
Table 97. Dongcheng Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 98. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 99. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Dongcheng Main Business
Table 101. Dongcheng Latest Developments
Table 102. Jaco Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 103. Jaco Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 104. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Jaco Main Business
Table 106. Jaco Latest Developments
Table 107. Ciaeriar Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 108. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 109. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Ciaeriar Main Business
Table 111. Ciaeriar Latest Developments
Table 112. Advanced Molecular-imaging Solution Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 113. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 114. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Advanced Molecular-imaging Solution Main Business
Table 116. Advanced Molecular-imaging Solution Latest Developments
Table 117. Shanghai Atom Kexing Basic Information, Nuclear Medicine & Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offered
Table 119. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Shanghai Atom Kexing Main Business
Table 121. Shanghai Atom Kexing Latest Developments
List of Figures
Figure 1. Picture of Nuclear Medicine & Radiopharmaceuticals
Figure 2. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diagnostic
Figure 10. Product Picture of Therapeutic
Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2021
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
Figure 13. Nuclear Medicine & Radiopharmaceuticals Consumed in Oncology
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Market: Oncology (2017-2022) & (K Units)
Figure 15. Nuclear Medicine & Radiopharmaceuticals Consumed in Thyroid
Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Market: Thyroid (2017-2022) & (K Units)
Figure 17. Nuclear Medicine & Radiopharmaceuticals Consumed in Cardiology
Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Market: Cardiology (2017-2022) & (K Units)
Figure 19. Nuclear Medicine & Radiopharmaceuticals Consumed in Others
Figure 20. Global Nuclear Medicine & Radiopharmaceuticals Market: Others (2017-2022) & (K Units)
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2022)
Figure 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application in 2021
Figure 23. Nuclear Medicine & Radiopharmaceuticals Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Company in 2021
Figure 25. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Geographic Region in 2021
Figure 27. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2017-2022)
Figure 28. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country/Region in 2021
Figure 29. Americas Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 30. Americas Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 31. APAC Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 32. APAC Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 33. Europe Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 34. Europe Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue 2017-2022 ($ Millions)
Figure 37. Americas Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 38. Americas Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 39. United States Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2021
Figure 44. APAC Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions in 2021
Figure 45. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 52. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 53. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2021
Figure 60. Egypt Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Nuclear Medicine & Radiopharmaceuticals Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Nuclear Medicine & Radiopharmaceuticals in 2021
Figure 66. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals
Figure 67. Industry Chain Structure of Nuclear Medicine & Radiopharmaceuticals
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
